347983 <common-name>N-(5-bromo-1,3-benzothiazol-2-yl)-4-(2,4-dimethoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,6,8-tetrahydroquinoline-3-carboxamide</common-name> <description>N-(5-bromo-1,3-benzothiazol-2-yl)-4-(2,4-dimethoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,6,8-tetrahydroquinoline-3-carboxamide is a chemical compound with the formula C28H28BrN3O4S. With an average molecular weight of 582.50 g/mol, N-(5-bromo-1,3-benzothiazol-2-yl)-4-(2,4-dimethoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,6,8-tetrahydroquinoline-3-carboxamide is a heavy molecule.</description> <cas>476483-18-8</cas> <pubchem-id>4662366</pubchem-id> <chemical-formula>C28H28BrN3O4S</chemical-formula> <weight>582.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T11:50:56Z</created-at> <updated-at type="dateTime">2026-08-31T11:50:56Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=C(C(C2=C(N1)CC(CC2=O)(C)C)C3=C(C=C(C=C3)OC)OC)C(=O)NC4=NC5=C(S4)C=CC(=C5)Br</moldb-smiles> <moldb-formula>C28H28BrN3O4S</moldb-formula> <moldb-inchi>InChI=1S/C28H28BrN3O4S/c1-14-23(26(34)32-27-31-18-10-15(29)6-9-22(18)37-27)24(17-8-7-16(35-4)11-21(17)36-5)25-19(30-14)12-28(2,3)13-20(25)33/h6-11,24,30H,12-13H2,1-5H3,(H,31,32,34)</moldb-inchi> <moldb-inchikey>ATXXQWIVFRLJFQ-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">581.09839</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.7</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM343876</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-(5-bromo-1,3-benzothiazol-2-yl)-4-(2,4-dimethoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,6,8-tetrahydroquinoline-3-carboxamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Quinolines and derivatives</klass> <subklass>Phenylquinolines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0298319</sync-id> <structure-inchikey>ATXXQWIVFRLJFQ-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400202000000000000000000040c040000000000024200000000000002041000000000000000000000002000040000000000000002000000000000080100020000030000100000a0080000100020004000001000000004000000010040000040002000800000200080000000010100100004800010000400020000000008400100c00000000000000000000002000020400000000000000000008020000000000000000008000010000000000008000000000020000000000010000100000000000000000200000020000000000000000a000000001000040000000000400000000000028000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKQAAAIABBgBgAAAAAQMGACgAAAAD BAYAKAAAAAMEBgBgAAAAAwEGACgAAAADBAYAKAAAAAMEBwBoAAAAAwIBBgBg AAAAAgIGACAAAAAEBgBgAAAAAgIGACgAAAADBAgAKAAAAAMCBgBgAAAAAQMG AGAAAAABAwZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZAaAAA AAMDAQZAaAAAAAMDAQgAKAAAAAMCBgBgAAAAAQMIACgAAAADAgYAYAAAAAED BgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQZAKAAAAAMEB0AoAAAAAwMGQCgA AAADBAZAKAAAAAMEEEAoAAAAAwIGQGgAAAADAwEGQGgAAAADAwEGQCgAAAAD BAZAaAAAAAMDASMAIAAAAAELAAEAAQIoAgIDAAMEAAQFKAIFBiAFBwAHCAAI CQAJCgAKCygCCAwACA0AAw4ADg9oDA8QaAwQEWgMERJoDBITaAwRFCAUFQAP FiAWFwACGCAYGSgCGBogGhsgGxxoDBwdaAwdHmgMHh9oDB4gaAwgIWgMISJo DCIjaAwiJAAGASAKBCATDmgMHxtoDCMdaAxCBQAAAAYBBgUEAwIGBwgJCgQF Bg8QERITDgUcGx8eHQYgISIjHR4XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:30Z</structure-indexed-at> </compound>